These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30581922)

  • 21. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. With whom should I work? Partners' network characteristics and innovation persistence.
    Ji J
    Heliyon; 2024 Jul; 10(13):e33966. PubMed ID: 39055822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue research networks: building evidence for policy and planning in Brazil.
    de Paula Fonseca E Fonseca B; Zicker F
    Health Res Policy Syst; 2016 Nov; 14(1):80. PubMed ID: 27825383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering Innovation Features and Emerging Technologies in Molecular Biology through Patent Analysis.
    Pereira CG; Porto GS
    Methods Mol Biol; 2018; 1674():15-34. PubMed ID: 28921425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sticking to the knitting: CIHR, innovation and Canadian biotech.
    Edelson J
    Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The socio-economic landscape of biotechnology in Spain. A comparative study using the innovation system concept.
    Díaz V; Muñoz E; de los Monteros JE; Senker J
    J Biotechnol; 2002 Sep; 98(1):25-40. PubMed ID: 12126803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Innovation in the Era of Global Surgery: A Network Analysis.
    Garas G; Cingolani I; Patel V; Panzarasa P; Alderson D; Darzi A; Athanasiou T
    Ann Surg; 2020 May; 271(5):868-874. PubMed ID: 30601251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innovation by coercion: Emerging institutionalization of university-industry collaborations in Russia.
    Bychkova O
    Soc Stud Sci; 2016 Aug; 46(4):511-535. PubMed ID: 28948870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective view on European pharmaceutical research and development. Policy options to reduce fragmentation and increase competitiveness.
    Kanavos P
    Pharmacoeconomics; 1998 Feb; 13(2):181-90. PubMed ID: 10178646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of knowledge transfer performance on the artificial intelligence industry innovation network: An empirical study of Chinese firms.
    Shi G; Ma Z; Feng J; Zhu F; Bai X; Gui B
    PLoS One; 2020; 15(5):e0232658. PubMed ID: 32421743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The motivations, institutions and organization of university-industry collaborations in the Netherlands.
    Bodas Freitas IM; Verspagen B
    J Evol Econ; 2017; 27(3):379-412. PubMed ID: 28736486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global or local: The future of biotech.
    Tse V; Schweizer L
    Drug Discov Today; 2023 May; 28(5):103528. PubMed ID: 36796755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enabling Europe to innovate.
    Dearing A
    Science; 2007 Jan; 315(5810):344-7. PubMed ID: 17234939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perception, reality, and the political context of conflict of interest in university-industry relationships.
    Frankel MS
    Acad Med; 1996 Dec; 71(12):1297-304. PubMed ID: 9114887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On slicing an obvious salami thinly: science, patent case law, and the fate of the early biotech sector in the making of EPO.
    Rasmussen N
    Perspect Biol Med; 2013; 56(2):198-222. PubMed ID: 23974501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can science be a business? Lessons from biotech.
    Pisano GP
    Harv Bus Rev; 2006 Oct; 84(10):114-24, 150. PubMed ID: 17040044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.